CDC

Yet another study shows that Neurontin is a poor substitute for prescription opioids, so why do physicians continue to prescribe it? Twitter recently put a warning on an ACSH obesity story. Is social-media censorship here to stay?
A new CDC survey shows that teen vaping is still declining. Oddly, the agency maintains that e-cigarette use among adolescents is an "epidemic."
Minnesota has become the leader in restoring the rights of patients to receive necessary pain medications as well as the doctors who prescribe them. It's a huge step. One down, 49 to go. Drs. Bloom and Singer in Newsweek.
Recent news reports alleged that new research has found a link between "forever chemicals" and liver cancer. This was an exaggeration of the results, to say the very least.
How are politicians similar to bacteria? ACSH advisor Dr. Henry Miller explains.
Cato Institute's Dr. Jeff Singer (also a member of the ACSH Scientific Advisory Board) is none too pleased with both the CDC and FDA and the way they've handled monkeypox. It seems lessons from COVID-19 have gone unlearned.
You can be blindfolded, throw a stone, and probably hit a writer who gets the opioid crisis all wrong. Today, let's throw one at German Lopez of The New York Times.
Recent coverage in the Washington Post illustrates how the media (and even some in the scientific community) have exaggerated the risk COVID-19 poses to the elderly and downplayed the efficacy of vaccination in this age group.
An unexpected delay in the FDA's authorization of COVID shots for children under age 5 could amplify parents' existing concerns about vaccinating their kids. Here's what we know about the situation.
Dozens of studies examining the effects of vaccine mandates have been published over the last year. A pre-print review of this literature has found that requiring COVID-19 vaccination may carry significant costs, including a deepening distrust of public health authorities and greater vaccine hesitancy.
Drs. Robert Popovian (a member of the Scientific Advisory Board at ACSH) and Radife Kiral, both at Pfizer, examine the response of our healthcare system to the COVID pandemic. In some areas we did well; in others not so well. What can we do better in the future?
Several superficially plausible arguments against COVID-19 vaccination continue to pop up across the internet, usually phrased as leading questions. Are they as solid as they seem? A little investigation suggests they are mostly speculation.